CPC Subgroup Additional Only
C12N 2320/30 Special therapeutic applications
Full Title
Applications; Uses > Special therapeutic applications
5 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12N 2320/31 Combination therapy
- C12N 2320/32 Special delivery means, e.g. tissue-specific
- C12N 2320/33 Alteration of splicing
- C12N 2320/34 Allele or polymorphism specific uses
- C12N 2320/35 based on a specific dosage / administration regimen
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692